# “Lookback” for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/lookback-for-hepatitis-c-virus-hcv-product-quarantine-consignee-notification-further-testing-product-disposition-and-notification-of-transfusion-recipients-based-on-donor-test-results-indicating-infection-with-hcv-guidance-for-industry/47e1cf90-16d8-4331-8148-46e9e88b7770

> FDA guidance document: “Lookback” for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV:  Guidance for Industry. Issue date: December 01, 2010. Get complete insights and analysis.

---

## Details

- Title: “Lookback” for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2010-12-01
- Last Changed: 2024-04-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-0002">FDA-1999-D-0002</a>

## Related Documents

- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Cellular Therapy for Cardiac Disease:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/cellular-therapy-for-cardiac-disease-guidance-for-industry/d0a87a21-c69d-46d1-b795-8481faf21a82)
- [Requalification Method for Reentry of Blood Donors Deferred Because of Reactive Test Results for Antibody to Hepatitis B Core Antigen (Anti-HBc):  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/requalification-method-for-reentry-of-blood-donors-deferred-because-of-reactive-test-results-for-antibody-to-hepatitis-b-core-antigen-anti-hbc-guidance-for-industry/277daaf6-6b78-49ea-be56-7a9c5a11d75e)